Home - IAVI

25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website

LATEST NEWS

Catherine Namugga Kibirige

Meet the IAVI scientist who developed a new HIV test for resource-limited settings

IAVI Report: A conversation with Jon Cohen on covering COVID-19

IAVI Report: The future of mRNA-based HIV vaccines is about more than speed

Computer illustration of antibodies attaching to HIV

IAVI-Moderna partner to tackle broad global health priorities using mRNA

eOD-GT8 60mer IAVI G002

IAVI and Moderna launch trial of HIV vaccine antigens with mRNA technology

TB vaccine research - MTBVAC

IAVI & Biofabri partner to advance TB vaccine candidate into efficacy trials

WHAT WE DO

What We Do

Discover

new approaches to developing vaccines and antibodies for HIV, TB, emerging infectious diseases, and neglected diseases.

Accelerate

translational and clinical research through our laboratories in the U.S., India, and the U.K.

Build Capacity

in-country for researching vaccine candidates while strengthening local public health and scientific expertise.

Partner

with industry and enlist biopharma product development skills to develop innovative products tailored to target populations.

Share

IAVI’s resources with other innovators to help the global health community as a whole succeed.

Extend

IAVI’s core capabilities to solving disease prevention and treatment challenges.

About

Our Work

Our Science

News & Resources

©2022 International AIDS Vaccine Initiative. International AIDS Vaccine Initiative^®, IAVI^®, and the IAVI logo^® are registered trademarks of the International AIDS Vaccine Initiative, Inc.